tiprankstipranks
Jubilant Ingrevia Ltd. (IN:JUBLINGREA)
:JUBLINGREA
India Market
Want to see IN:JUBLINGREA full AI Analyst Report?

Jubilant Ingrevia Ltd. (JUBLINGREA) Price & Analysis

2 Followers

JUBLINGREA Stock Chart & Stats

₹726.00
-₹47.65(-5.70%)
At close: 4:00 PM EST
₹726.00
-₹47.65(-5.70%)

Bulls Say, Bears Say

Bulls Say
Diversified B2B Product MixJubilant Ingrevia's diversified B2B portfolio spanning specialty chemicals, nutrition ingredients and intermediates reduces reliance on a single end-market. This structural diversity supports revenue resilience across cycles, enables cross‑selling to industrial and pharma customers, and allows a shift toward higher‑margin specialty products over time.
Manageable Leverage And Equity GrowthA moderate leverage profile (D/E ~0.25) plus steady equity growth provides financial flexibility to fund capex, absorb cyclical downturns, and pursue strategic investments without over-reliance on short‑term debt. This balance sheet position supports durable operational continuity and investment optionality.
Consistent Positive Operating Cash FlowSustained positive operating cash flow over several years signals the underlying business generates real cash from operations, enabling funding for working capital, reinvestment, and debt servicing. Over the medium term this cash base supports strategic spending even if free cash flow is more volatile.
Bears Say
Weak Cash Conversion & Volatile FCFLow cash conversion (operating cash well below net income) and volatile free cash flow limit the company's ability to consistently self‑fund growth or return capital. Over 2–6 months this raises dependence on external financing for working capital or capex and increases vulnerability to margin shocks.
Margins Below Prior-cycle HighsSustained margin compression relative to prior-cycle peaks suggests structural pricing pressure or higher input/energy costs. Persistently lower margins reduce earnings power and ROE, constrain reinvestment capacity, and make the business more sensitive to volume fluctuations in key end markets.
Declining Capital Efficiency (ROE Trend)A multi-year decline in return on equity indicates weaker capital efficiency, possibly from lower margins or underutilized assets. Over the medium term this trend erodes shareholder value creation and increases pressure on management to improve margins, asset turnover, or pursue restructuring to restore returns.

Jubilant Ingrevia Ltd. News

JUBLINGREA FAQ

What was Jubilant Ingrevia Ltd.’s price range in the past 12 months?
Jubilant Ingrevia Ltd. lowest stock price was ₹535.30 and its highest was ₹851.85 in the past 12 months.
    What is Jubilant Ingrevia Ltd.’s market cap?
    Jubilant Ingrevia Ltd.’s market cap is ₹101.62B.
      When is Jubilant Ingrevia Ltd.’s upcoming earnings report date?
      Jubilant Ingrevia Ltd.’s upcoming earnings report date is Jul 21, 2026 which is in 33 days.
        How were Jubilant Ingrevia Ltd.’s earnings last quarter?
        Jubilant Ingrevia Ltd. released its earnings results on May 26, 2026. The company reported ₹5.5 earnings per share for the quarter, beating the consensus estimate of ₹4.35 by ₹1.15.
          Is Jubilant Ingrevia Ltd. overvalued?
          According to Wall Street analysts Jubilant Ingrevia Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Jubilant Ingrevia Ltd. pay dividends?
            Jubilant Ingrevia Ltd. pays a Semiannually dividend of ₹2.5 which represents an annual dividend yield of 0.74%. See more information on Jubilant Ingrevia Ltd. dividends here
              What is Jubilant Ingrevia Ltd.’s EPS estimate?
              Jubilant Ingrevia Ltd.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Jubilant Ingrevia Ltd. have?
              Jubilant Ingrevia Ltd. has 159,281,140 shares outstanding.
                What happened to Jubilant Ingrevia Ltd.’s price movement after its last earnings report?
                Jubilant Ingrevia Ltd. reported an EPS of ₹5.5 in its last earnings report, beating expectations of ₹4.35. Following the earnings report the stock price went down -4.492%.
                  Which hedge fund is a major shareholder of Jubilant Ingrevia Ltd.?
                  Currently, no hedge funds are holding shares in IN:JUBLINGREA
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Jubilant Ingrevia Ltd.

                    Jubilant Ingrevia Limited, established in 2019 and based in Noida, India, is a global supplier of life science products and comprehensive solutions. The company's operations are divided into three core divisions: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment delivers a variety of specialized ingredients, fine chemicals, and crop protection agents, in addition to offering custom development and manufacturing (CDMO) services. Its Nutrition & Health Solutions division focuses on ingredients for both human and animal nutrition and well-being. Meanwhile, the Life Science Chemicals segment provides crucial life science components and a range of specialized ethanol products. Jubilant Ingrevia's extensive portfolio encompasses numerous chemical offerings, including a broad spectrum of pyridine derivatives (such as picolines, cyanopyridines, and various substituted pyridines), essential vitamins like B3 and riboflavin phosphate sodium, and nutritional compounds like premixes and antioxidants. They also produce industrial chemicals like acetic anhydride, ethyl acetate, and various alcohols (absolute alcohol, ethanol), alongside biocompost and gas mixtures. Furthermore, the company supplies a wide array of animal health and nutrition additives, including mineral premixes, stress regulators, amino acids, herbal growth promoters, toxin binders, and enzymes. Beyond its product range, Jubilant Ingrevia offers specialized services in chemical synthesis, covering everything from initial route design and process optimization to scaling up production and commercial manufacturing of intermediates. The company serves a diverse client base across the pharmaceutical, nutrition, agrochemical, consumer goods, and industrial sectors. Originally incorporated as Jubilant LSI Limited, the company adopted its current name, Jubilant Ingrevia Limited, in October 2020.

                    Jubilant Ingrevia Ltd. (JUBLINGREA) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Concord Biotech Ltd.
                    Dishman Carbogen Amcis Ltd.
                    Piramal Pharma Limited
                    Syngene International Ltd.
                    OneSource Specialty Pharma Limited
                    Popular Stocks